Abstract
Lipoic acid (LA) is an antioxidant with therapeutic properties on several diseases like diabetes and obesity. Apelin is a novel adipokine with potential beneficial actions on glucose metabolism and insulin resistance. The aim of this study was to examine in 3T3-L1 adipocytes the effects of LA on apelin gene expression and secretion, as well as elucidate the signaling pathways involved. We also tested the regulation of adipose apelin gene expression by LA supplementation in a model of high-fat diet-induced obesity. LA increased apelin secretion but not apelin gene expression in 3T3-L1 adipocytes. The AMPK inhibitor Compound C induced an increase in LA-stimulated apelin production, and, on the contrary, the AMPK activator AICAR completely reversed the LA stimulatory effects on apelin secretion, also inducing a significant reduction in apelin mRNA levels in this in vitro model. Apelin mRNA levels were increased in those animals fed with the high-fat diet, while the caloric restriction decreased apelin mRNA to control levels. However, apelin gene expression was not significantly modified in rats treated with LA compared with the obese group. The current data suggest the ability of LA to modulate apelin secretion by adipocytes. However the insulin-sensitizing effect of LA in vivo is not related to changes in apelin gene expression in our model of diet-induced obesity.
Similar content being viewed by others
References
Attane C, Daviaud D, Dray C, Dusaulcy R, Masseboeuf M, Prevot D, Carpene C, Castan-Laurell I, Valet P (2011) Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. J Mol Endocrinol 46:21–28
Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–1771
Butler JA, Hagen TM, Moreau R (2009) Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 485:63–71
Carbonelli MG, Di Renzo L, Bigioni M, Di Daniele N, De Lorenzo A, Fusco MA (2010) Alpha-lipoic acid supplementation: a tool for obesity therapy? Curr Pharm Des 16:840–846
Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI, Castan-Laurell I (2007) Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63:359–373
Castan-Laurell I, Boucher J, Dray C, Daviaud D, Guigne C, Valet P (2005) Apelin, a novel adipokine over-produced in obesity: friend or foe? Mol Cell Endocrinol 245:7–9
Cinti S (2005) The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73:9–15
Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS, Valet P, Castan-Laurell I (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20:1528–1530
Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attane C, Wanecq E, Guigne C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I (2010) Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab 298:E1161–E1169
Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C, Burcelin R, Castan-Laurell I, Valet P (2008) Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8:437–445
Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, Klip A (1996) Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45:1798–1804
Garcia-Diaz D, Campion J, Milagro FI, Martinez JA (2007) Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 305:87–94
Huong D, Ide T (2008) Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats. Br J Nutr 100:79–87
Kapica M, Puzio I, Kato I, Kuwahara A, Zabielski R (2008) Role of feed-regulating peptides on pancreatic exocrine secretion. J Physiol Pharmacol 59(Suppl 2):145–159
Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU (2004) Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10:727–733
Koh EH, Lee WJ, Kim MS, Park JY, Lee IK, Lee KU (2005) Intracellular fatty acid metabolism in skeletal muscle and insulin resistance. Curr Diabetes Rev 1:331–336
Lee WJ, Lee IK, Kim HS, Kim YM, Koh EH, Won JC, Han SM, Kim MS, Jo I, Oh GT, Park IS, Youn JH, Park SW, Lee KU, Park JY (2005) Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol 25:2488–2494
Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY (2005) Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332:885–891
Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K (2006) Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 114:544–548
Lorente-Cebrian S, Bustos M, Marti A, Martinez JA, Moreno-Aliaga MJ (2009) Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin Sci (Lond) 117:243–249
Lorente-Cebrian S, Bustos M, Marti A, Martinez JA, Moreno-Aliaga MJ (2010) Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes. Mol Nutr Food Res 54(Suppl 1):S104–S111
Moreno-Aliaga MJ, Matsumura F (2002) Effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p, p'-DDT) on 3T3-L1 and 3T3-F442A adipocyte differentiation. Biochem Pharmacol 63:997–1007
Packer L, Kraemer K, Rimbach G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888–895
Park KG, Min AK, Koh EH, Kim HS, Kim MO, Park HS, Kim YD, Yoon TS, Jang BK, Hwang JS, Kim JB, Choi HS, Park JY, Lee IK, Lee KU (2008) Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 48:1477–1486
Perez-Echarri N, Perez-Matute P, Marcos-Gomez B, Martinez JA, Moreno-Aliaga MJ (2009) Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats. Br J Nutr 101:1059–1067
Perez-Matute P, Marti A, Martinez JA, Fernandez-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ (2005) Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol 288:R1682–R1688
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martinez JA, Moreno-Aliaga MJ (2009) Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. J Physiol Biochem 65:43–50
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martínez JA, Moreno-Aliaga MJ (2009) Effects of dietary supplementation with lipoic acid on leptin and adiponectin plasma levels in lean and obese Wistar rats. Acta Physiol 195(suppl 667):129
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martinez JA, Moreno-Aliaga MJ (2011) Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol Nutr Food Res. doi:10.1002/mnfr.201000534
Purnell JQ, Hirsch IB (1997) New oral therapies for type 2 diabetes. Am Fam Physician 56:1835–1842
Quazi R, Palaniswamy C, Frishman WH (2009) The emerging role of apelin in cardiovascular disease and health. Cardiol Rev 17:283–286
Ringstrom C, Nitert MD, Bennet H, Fex M, Valet P, Rehfeld JF, Friis-Hansen L, Wierup N (2010) Apelin is a novel islet peptide. Regul Pept 162:44–51
Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N (1999) Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42:949–957
Sena CM, Nunes E, Louro T, Proenca T, Fernandes R, Boarder MR, Seica RM (2008) Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol 153:894–906
Sena CM, Nunes E, Louro T, Proenca T, Seica RM (2007) Endothelial dysfunction in type 2 diabetes: effect of antioxidants. Rev Port Cardiol 26:609–619
Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM (2004) Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 11:1135–1146
Song KH, Lee WJ, Koh JM, Kim HS, Youn JY, Park HS, Koh EH, Kim MS, Youn JH, Lee KU, Park JY (2005) Alpha-lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. Biochem Biophys Res Commun 326:197–202
Wei L, Hou X, Tatemoto K (2005) Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 132:27–32
Xu DP, Wells WW (1996) Alpha-lipoic acid dependent regeneration of ascorbic acid from dehydroascorbic acid in rat liver mitochondria. J Bioenerg Biomembr 28:77–85
Acknowledgements
This work has been supported, in part, by Ministerio de Ciencia e Innovación of Spain (AGL2006-04716/ALI and AGL2009-10873/ALI) and Línea Especial de Investigación “Nutrición, Obesidad y Salud” (University of Navarra LE/97).
M. Fernández-Galilea was supported by a predoctoral grant by the “Asociación de Amigos de la Universidad de Navarra”. CTP Network is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Galilea, M., Pérez-Matute, P., Prieto-Hontoria, P. et al. Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats. J Physiol Biochem 67, 479–486 (2011). https://doi.org/10.1007/s13105-011-0087-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-011-0087-1